07:30-08:15
Satellite Symposium 3:
74
Novartis Korea Ltd.
Room 1 (Vista 1+2)
74
08:30-09:45
Symposium 5:
12
Biomarker-Driven Adaptive Surgery in the Era of Neoadjuvant Therapy
Room 1 (Vista 1+2)
12
Panel Discussion 4:
23
Current Landscapes and Future Prospectives of HER2 low/ultralow Breast Cancer
Room 2 (Grand 1)
23
Symposium 6:
13
AI Across Breast Imaging
Room 3 (Walker 1)
13
Nursing Session 1 (Kor.):
62
From Surgery to Systemic Therapy: Managing Physical Complication in Breast Cancer Care
Room 4 (Walker 2)
62
GBCC-JBCS-TBCS Joint Session:
53
Current Evidence of Ovarian Function Suppression and Real-World Practice in Asia
Room 5 (Art Hall)
53
10:00-11:15
General Session 2
44
Room 1 (Vista 1+2)
44
Multidisciplinary Session:
35
Integrating AI into Cancer Treatment
Room 2 (Grand 1)
35
Education Session 2:
27
Modern Axillary Care in Breast Cancer: Integrating Surgical, Imaging and Pathologic Insights
Room 3 (Walker 1)
27
Nursing Session 2 (Kor.):
72
Unmet Needs and Holistic Care in Patient with Metastatic or Recurrent Breast Cancer
Room 4 (Walker 2)
72
Mini Oral Presentation 3
71
Room 5 (Art Hall)
71
11:30-12:15
Plenary Lecture 3:
4
Next Generation ADCs
Room 1 (Vista 1+2)
4
12:30-13:15
Satellite Symposium 4:
64
Daiichi-Sankyo Korea
Room 1 (Vista 1+2)
64
Satellite Symposium 5:
65
Roche Korea co.,ltd
Room 2 (Grand 1)
65
13:30-14:15
Plenary Lecture 4:
5
What Does it Take to Make Precision Oncology Precise?
Room 1 (Vista 1+2)
5
14:30-15:20
Junior Doctors Forum
55
Room 4 (Walker 2)
55
14:30-15:45
Symposium 7:
14
Evolving Landscape of HR+/HER2- Metastatic Breast Cancer Treatment
Room 1 (Vista 1+2)
14
Panel Discussion 5:
66
Modern Axillary Management in Breast Cancer with Regional Nodal Involvement
Room 2 (Grand 1)
66
Education Session 3:
29
Breast Cancer Related Lymphedema: Etiologic Factors and Risk Stratification
Room 3 (Walker 1)
29
Mini Oral Presentation 4
67
Room 5 (Art Hall)
67
15:35-17:15
Junior Doctors Debate
56
Room 4 (Walker 2)
56
16:00-17:15
Symposium 8:
15
De-escalation of Breast Cancer Surgery: What We Know vs. What We Actually Do
Room 1 (Vista 1+2)
15
Symposium 9:
16
Shaping the Future of Breast Cancer Treatment with Antibody Drug Conjugates
Room 2 (Grand 1)
16
Education Session 4:
30
Locoregional Management for Lymph Node Positive Breast Cancer
Room 3 (Walker 1)
30
Education Session 5:
31
Enhancing and Optimizing Survivorship Throughout Cancer Treatment
Room 5 (Art Hall)
31